Works about INDUCTION chemotherapy


Results: 670
    1
    2
    3
    4
    5
    6
    7

    Cytarabine Pharmacogenomics and Outcomes Among Children and Young Adults With Acute Myeloid Leukemia.

    Published in:
    JAMA Network Open, 2025, v. 8, n. 6, p. e2516296, doi. 10.1001/jamanetworkopen.2025.16296
    By:
    • Marrero, Richard J.;
    • Shastri, Vivek M.;
    • Nicolet, Deedra;
    • Mrózek, Krzysztof;
    • Walker, Christopher J.;
    • Blum, William G.;
    • Powell, Bayard L.;
    • Kolitz, Jonathan E.;
    • Moore, Joseph O.;
    • Uy, Geoffrey L.;
    • Stock, Wendy;
    • Carroll, Andrew J.;
    • Byrd, John C.;
    • Aplenc, Richard;
    • Cooper, Todd M.;
    • Gamis, Alan S.;
    • Wu, Huiyun;
    • Pounds, Stanley;
    • Wang, Yi-Cheng;
    • Alonzo, Todd A.
    Publication type:
    Article
    8

    Induction or Adjuvant Chemotherapy in Patients with Locally Advanced Nasopharyngeal Cancer Receiving Chemoradiotherapy? A Turkish Oncology Group Study.

    Published in:
    Journal of Clinical Medicine, 2025, v. 14, n. 12, p. 4189, doi. 10.3390/jcm14124189
    By:
    • Sekmek, Serhat;
    • Oguz, Aysel;
    • Karakurt Eryilmaz, Melek;
    • Araz, Murat;
    • Biter, Sedat;
    • Kıdı, Mehmet Mutlu;
    • Bayram, Ertugrul;
    • Erdat, Efe Cem;
    • Yasar, Arzu;
    • Colak, Rumeysa;
    • Yilmaz, Mesut;
    • Bakir Kahveci, Gizem;
    • Divriklioglu, Didem;
    • Chalabiyev, Elvin;
    • Aksoy, Sercan;
    • Ozsan Celebi, Sema Nur;
    • Kosku, Hakan;
    • Yılmaz, Mesut;
    • Hacibekiroglu, Ilhan;
    • Temizyurek, Haydar
    Publication type:
    Article
    9
    10
    11
    12

    The prognostic impact of the lymphocyte-to-C-reactive protein ratio in patients with unresectable or recurrent advanced gastric cancer treated with first- and second-line treatment.

    Published in:
    Surgery Today, 2023, v. 53, n. 8, p. 940, doi. 10.1007/s00595-022-02638-w
    By:
    • Matsunaga, Tomoyuki;
    • Saito, Hiroaki;
    • Fukumoto, Yoji;
    • Kuroda, Hirohiko;
    • Taniguchi, Kenjiro;
    • Takahashi, Sadamu;
    • Osaki, Tomohiro;
    • Iwamoto, Akemi;
    • Fukuda, Kenji;
    • Shimizu, Shota;
    • Shishido, Yuji;
    • Miyatani, Kozo;
    • Fujiwara, Yoshiyuki
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers.

    Published in:
    Journal of Clinical Medicine, 2025, v. 14, n. 3, p. 700, doi. 10.3390/jcm14030700
    By:
    • Battaglia, Giulia;
    • Lazzarotto, Davide;
    • Tanasi, Ilaria;
    • Gurrieri, Carmela;
    • Forlani, Laura;
    • Mauro, Endri;
    • Capraro, Francesca;
    • Ciotti, Giulia;
    • De Bellis, Eleonora;
    • Callegari, Chiara;
    • Tosoni, Luca;
    • Fanin, Matteo;
    • Morelli, Gian Luca;
    • Simio, Claudia;
    • Skert, Cristina;
    • Gottardi, Michele;
    • Zaja, Francesco;
    • Toffoletti, Eleonora;
    • Damiani, Daniela;
    • Fanin, Renato
    Publication type:
    Article
    24
    25
    26
    27

    A Review of FLT3 Kinase Inhibitors in AML.

    Published in:
    Journal of Clinical Medicine, 2023, v. 12, n. 20, p. 6429, doi. 10.3390/jcm12206429
    By:
    • Negotei, Cristina;
    • Colita, Andrei;
    • Mitu, Iuliana;
    • Lupu, Anca Roxana;
    • Lapadat, Mihai-Emilian;
    • Popovici, Constanta Elena;
    • Crainicu, Madalina;
    • Stanca, Oana;
    • Berbec, Nicoleta Mariana
    Publication type:
    Article
    28
    29

    Docetaxel-Cisplatin-Fluorouracil Induction Chemotherapy for Larynx Preservation in Patients with Locally Advanced Hypopharyngeal Cancer: Predictive Factors of Oncologic and Functional Outcomes.

    Published in:
    Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 1131, doi. 10.3390/jcm12031131
    By:
    • Mattei, Pierre;
    • Gal, Jocelyn;
    • Chamorey, Emmanuel;
    • Dassonville, Olivier;
    • Poissonnet, Gilles;
    • Aloi, Déborah;
    • Barret, Médéric;
    • Safta, Inga;
    • Saada, Esma;
    • Sudaka, Anne;
    • Culié, Dorian;
    • Bozec, Alexandre
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37

    The ASCENT Trial: a phase 2 study of induction and consolidation afatinib and chemoradiation with or without surgery in stage III EGFR-mutant NSCLC.

    Published in:
    Oncologist, 2024, v. 29, n. 7, p. 609, doi. 10.1093/oncolo/oyae107
    By:
    • Chang, Allison E B;
    • Piper-Vallillo, Andrew J;
    • Mak, Raymond H;
    • Lanuti, Michael;
    • Muzikansky, Alona;
    • Rotow, Julia;
    • Jänne, Pasi A;
    • Mino-Kenudson, Mari;
    • Swanson, Scott;
    • Wright, Cameron D;
    • Kozono, David;
    • Marcoux, Paul;
    • Piotrowska, Zofia;
    • Sequist, Lecia V;
    • Willers, Henning
    Publication type:
    Article
    38
    39
    40
    41

    Early efficacy and safety of obinutuzumab with chemotherapy in previously untreated patients with follicular lymphoma: A real-world retrospective report of the Polish Lymphoma Research Group.

    Published in:
    Advances in Clinical & Experimental Medicine, 2023, v. 32, n. 1, p. 131, doi. 10.17219/acem/157290
    By:
    • Paszkiewicz-Kozik, Ewa;
    • Hus, Iwona;
    • Palka, Monika;
    • Dębowska, Małgorzata;
    • Końska, Agnieszka;
    • Kotarska, Martyna;
    • Tyczyńska, Agata;
    • Joks, Monika;
    • Twardosz, Maja;
    • Giza, Agnieszka;
    • Wąsik-Szczepanek, Ewa;
    • Kalicińska, Elżbieta;
    • Wiśniewska, Anna;
    • Morawska, Marta;
    • Lewicka, Barbara;
    • Szymański, Marcin;
    • Targoński, Łukasz;
    • Romejko-Jarosińska, Joanna;
    • Drozd-Sokołowska, Joanna;
    • Subocz, Edyta
    Publication type:
    Article
    42
    43

    Safety and Pharmacokinetics of Quizartinib Combination Therapy With Standard Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results from Two Phase 1 Trials in Japan and China.

    Published in:
    Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 560, doi. 10.1002/cpdd.1353
    By:
    • Qi, Junyuan;
    • Choi, Ilseung;
    • Ota, Shuichi;
    • Ichikawa, Satoshi;
    • Fujishima, Naohito;
    • Iida, Hiroatsu;
    • Sugiura, Isamu;
    • Sugiura, Koichi;
    • Murata, Yasuharu;
    • Inoue, Hiroyuki;
    • Ohwada, Shoichi;
    • Wang, Jianxiang
    Publication type:
    Article
    44
    45
    46
    47
    48
    49

    Association between hypogammaglobulinaemia and severe infections during induction therapy in ANCA-associated vasculitis: from J-CANVAS study.

    Published in:
    Rheumatology, 2023, v. 62, n. 12, p. 3924, doi. 10.1093/rheumatology/kead138
    By:
    • Omura, Satoshi;
    • Kida, Takashi;
    • Noma, Hisashi;
    • Sunaga, Atsuhiko;
    • Kusuoka, Hiroaki;
    • Kadoya, Masatoshi;
    • Nakagomi, Daiki;
    • Abe, Yoshiyuki;
    • Takizawa, Naoho;
    • Nomura, Atsushi;
    • Kukida, Yuji;
    • Kondo, Naoya;
    • Yamano, Yasuhiko;
    • Yanagida, Takuya;
    • Endo, Koji;
    • Hirata, Shintaro;
    • Matsui, Kiyoshi;
    • Takeuchi, Tohru;
    • Ichinose, Kunihiro;
    • Kato, Masaru
    Publication type:
    Article
    50